Main Theme: “Basic Immunology Research in Allergy and Clinical Immunology”


74 doctoral and postdoctoral scientists from 20 different countries attended the 4th EAACI-GA²LEN Davos Meeting “Basic Immunology Research in Allergy and Clinical Immunology” that took place between the 16th and the 19th of February 2006 in Grainau, Garmisch-Partenkirchen, Germany. The meeting was organized by the EAACI Immunology Section and the ZAUM-Center for Allergy and Environment, Technical University Munich, and was made possible by the generous support from GA²LEN.


Thilo Jakob and the Local Organizing Committee welcomed us at the Eibsee Hotel right at the foot of Germany`s highest mountain, the “Zugspitze” for a three-day meeting of highest scientific standards. The meeting included 6 symposia on 3 main topics: innate immunity, adaptive immunity and regulation and allergic inflammation. Each of the symposia was introduced by outstanding keynote lectures from some of the most renowned speakers in the field of basic immunology: Philippa Marrack, Hermann Wagner, Ron Germain, Richard Flavell, Ulrich von Andrian and Dale Umetsu proved their exceptional scientific and rhetorical reputations while covering cutting edge developments in the fields of innate and adaptive immunity, regulation of the immune response and mechanisms of allergic inflammation. In the morning and evening, keynote lectures were followed by excellent presentations selected from the submitted abstracts. For both keynote lectures and oral presentations ample time was reserved for the often passionate and vivid discussions.




Between the morning and the afternoon sessions there was just enough time to stretch your legs either by down hill skiing at the Zugspitze or by cross country skiing in the scenic mountainside of Bavaria. As in previous years, the after dinner poster sessions were a great success and gave young scientists the opportunity to directly interact with known capacities in the field. Active poster discussion still going on at midnight clearly demonstrated that the organizers had managed to create an engaging warm atmosphere in which it was possible to discuss controversial concepts, exchange novel ideas and built new friendships personally and scientifically.




During the closing, Anthony Frew, acting president of the EAACI, announced that this kind of meetings will continue, and that the planning of the 5th EAACI-GA²LEN Davos meeting “Basic Immunology Research in Allergy and Asthma” is already underway. Details will be announced via the GA²LEN and the EAACI web page.


Read also:
- 2006 Davos Meeting: The Abstracts!

Last updated 14 July 2009

Basic and Clinical Immunology Section - About Us

The immune system is able to distinguish self from non-self and dangerous from harmless. Allergic diseases represent the most notable failure in this system. The understanding, the research, diagnosis and management of allergies are therefore always related to immunology. Biologicals are becoming available that can selectively correct overshooting immune reactions. At the same time the costs of treatments increase and personalized approaches along with a sophisticated biomarker diagnosis are required to focus expenses to those patients who are most likely to benefit from it.

Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback